Protection of Mice by a λ-Based Therapeutic Vaccine against Cancer Associated with Human Papillomavirus Type 16

Publisher： Karger

E-ISSN： 1423-0100|54|3|105-112

ISSN： 0300-5526

Source： Intervirology, Vol.54, Iss.3, 2010-10, pp. : 105-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Case of Verrucous Carcinoma Associated with Human Papillomavirus Type 16 DNA

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 8, 1993-08 ,pp. : 483-488

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human papillomavirus type 16 E5 protein

By Bravo Ignacio G.   Alonso Angel   Auvinen Eeva  

Papillomavirus Report, Vol. 15, Iss. 1, 2004-01 ,pp. : 1-6

Maney Publishing

Access to resources Recommend Favorite

Prophylactic human papillomavirus vaccine

By Paavonen Jorma   Lehtinen Matti  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 5-6

Future Medicine

Access to resources Recommend Favorite

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

By Fastrez Maxime   Naik Haresh Nishan   Corfers Aurore   Rozenberg Serge  

Annals of Medicine, Vol. 44, Iss. 4, 2012-06 ,pp. : 404-404

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic human papillomavirus vaccination

By Kaufmann Andreas M   Schneider Achim  

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 339-348

Future Medicine

Access to resources Recommend Favorite